77903-28-7 Usage
General Description
5-methoxy-4-methylpyridin-3-amine is a chemical compound with the molecular formula C7H10N2O. It is a derivative of pyridine, containing a methoxy group at the 5-position and a methyl group at the 4-position of the pyridine ring. The amine group is located at the 3-position of the pyridine ring. 5-methoxy-4-methylpyridin-3-amine may have potential applications in pharmaceutical research, particularly in the development of new drugs targeting specific receptors or enzymes. Additionally, it may also be used as a building block in organic synthesis for the production of other chemical compounds with similar structural features. Further research and experimentation may be necessary to fully understand and utilize the properties and potential uses of 5-methoxy-4-methylpyridin-3-amine.
Check Digit Verification of cas no
The CAS Registry Mumber 77903-28-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,7,9,0 and 3 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 77903-28:
(7*7)+(6*7)+(5*9)+(4*0)+(3*3)+(2*2)+(1*8)=157
157 % 10 = 7
So 77903-28-7 is a valid CAS Registry Number.
77903-28-7Relevant articles and documents
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections
Magee, Thomas V.,Ripp, Sharon L.,Li, Bryan,Buzon, Richard A.,Chupak, Lou,Dougherty, Thomas J.,Finegan, Steven M.,Girard, Dennis,Hagen, Anne E.,Falcone, Michael J.,Farley, Kathleen A.,Granskog, Karl,Hardink, Joel R.,Huband, Michael D.,Kamicker, Barbara J.,Kaneko, Takushi,Knickerbocker, Michael J.,Liras, Jennifer L.,Marra, Andrea,Medina, Ivy,Nguyen, Thuy-Trinh,Noe, Mark C.,Obach, R. Scott,O'Donnell, John P.,Penzien, Joseph B.,Reilly, Usa Datta,Schafer, John R.,Shen, Yue,Stone, Gregory G.,Strelevitz, Timothy J.,Sun, Jianmin,Tait-Kamradt, Amelia,Vaz, Alfin D. N.,Whipple, David A.,Widlicka, Daniel W.,Wishka, Donn G.,Wolkowski, Joanna P.,Flanagan, Mark E.
experimental part, p. 7446 - 7457 (2010/06/13)
Respiratory tract bacterial strains are becoming increasingly resistant to currently marketed macrolide antibiotics. The current alternative telithromycin (1) from the newer ketolide class of macrolides addresses resistance but is hampered by serious safe
